| Previous Close | 72.60 |
| Open | 72.66 |
| Bid | 73.53 x 200 |
| Ask | 73.54 x 700 |
| Day's Range | 72.65 - 73.76 |
| 52 Week Range | 63.76 - 82.10 |
| Volume | 2,604,808 |
| Avg. Volume | 8,720,937 |
| Market Cap | 95.93B |
| Beta | 1.08 |
| PE Ratio (TTM) | 7.76 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.88%) |
| Ex-Dividend Date | 2017-09-14 |
| 1y Target Est | N/A |
- Zacks•3 hours ago
Alkermes Initiates Rolling Submission of Depression Drug
Alkermes (ALKS) initiated the rolling submission of a New Drug Application (NDA) to the FDA for pipeline candidate ALKS 5461 for major depressive disorder.
- Zacks•4 hours ago
4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
Here is a look at four biotech stocks including Gilead (GILD) that topped estimates in Q2 and are witnessing upward estimate revisions for the current year.
- Zacks•4 hours ago
Alexion's (ALXN) Soliris' Label Expansion Approved in Europe
Alexion Pharmaceuticals (ALXN) announced that the European Commission (EC) approved a label expansion of lead drug Soliris which should further boost sales.
